RecruitingPhase 1NCT05152368
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Enrollment
20 participants
Start Date
Sep 9, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This trial will study the safety and efficacy of instillation of cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes for the treatment of Trigeminal Neuralgia.
Eligibility
Inclusion Criteria2
- Diagnosis of Trigeminal Neuralgia or Peripheral Neuropathy
- Understanding and willingness to sign a written informed consent document
Exclusion Criteria10
- Active infection
- Active cancer
- Chronic multisystem organ failure
- Pregnancy
- Clinically significant Abnormalities on pre-treatment laboratory evaluation
- Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
- Continued drug abuse
- Pre-menopausal women not using contraception
- Previous organ transplant
- Hypersensitivity to sulfur
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALAlloEx
cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05152368
Related Trials
WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
NCT059506591 location
RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia
NCT075964851 location
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
NCT071098171 location
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
NCT054042304 locations
Investigational Use of Neuromuscular Ultrasound
NCT052379731 location